Brief: Tianjin Teda Biomedical Engineering receives notice from CSRC regarding issue of new H shares
Aug 7 (Reuters) - Tianjin Teda Biomedical Engineering Co Ltd
8189.HK
* Board passed resolution on 17 July 2017 & proposed to
issue additional H shares of not more than 199.5 million shares
* Received on 7 August 2017 "Acceptance Notice Of
Application For Administrative Permission From CSRC"
* Notice from CSRC indicates CSRC will commence review on
application of co for permission of issue of new H shares
Source text for Eikon: ID:nHKS5rN3QB
Further company coverage: 8189.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Tianjin Teda Biomedical Engineering Co
See all newsBrief: Tianjin Teda Biomedical Engineering Appoints Lynn Li As Joint CEO, Re-Designates Sun Li As Joint CEO
Brief: Tianjin Teda Biomedical Engineering Signs AI Healthcare Cooperation Agreement
Brief: Tianjin Teda Biomedical Engineering Says Unit Enters Strategic Cooperation
Brief: Tianjin Teda Biomedical Engineering Says Zhongtai International Securities To Procure Placees
Brief: Tianjin Teda Biomedical Engineering Says Re-Designation Of He Xin To Non-Executive Director